BLTE logo

BLTEBelite Bio Inc

$143.35
$1.11
(0.77%)
Today
Closed $143.35
$0.00
(0.00%)
After Hours
Updated: 05:55 PM EDT
Reported EarningsMay 20
Mkt Cap$5.75B
Vol333,834.00

About

Belite Bio, Inc. engages in the research and development of drugs. It focuses on the treatment of eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease. It also caters to metabolic diseases such as non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, type 2 diabetes, and gout. The company was founded by Yu-Hsin Lin on March 27, 2018 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
41

Frequently Asked Questions

What is Market Cap of Belite Bio Inc - ADR?
What is the 52-week high for Belite Bio Inc - ADR?
What is the 52-week low for Belite Bio Inc - ADR?
What is Belite Bio Inc - ADR stock price today?
What was Belite Bio Inc - ADR stock price yesterday?
What is the PE ratio of Belite Bio Inc - ADR?
What is the Price-to-Book ratio of Belite Bio Inc - ADR?
What is the 50-day moving average of Belite Bio Inc - ADR?
How many employees does Belite Bio Inc - ADR have?

Advertisement|Remove ads.